Simcere Pharmaceutical Group Limited Announces Findings of A Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in Jama

On February 19, 2024, the Journal of American Medical Association?Neurology published online the key findings of a phase III clinical study investigating Sanbexin® sublingual tablets for the...

Related Keywords

United States ,China ,American , ,Journal Of American Medical Association ,Simcere Pharmaceutical Group Ltd ,Neurodawn Pharmaceutical Co ,Ltd Neurodawn ,National Medical Products Administration Of China ,American Medical ,Simcere Pharmaceutical Group ,Neurodawn Pharmaceutical ,Dexborneol Concentrated Solution ,New Drug Application ,National Medical Products Administration ,Markets ,